Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil
International Journal of Drug Policy February 18, 2026 Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto et al.
Psilocybin has shown significant promise in enhancing mental health, with studies indicating a 60% reduction in depression symptoms among participants. In a sample of 200 individuals, 75% reported improved emotional well-being after psilocybin therapy. This highlights the potential for psychedelics to inform public health and policy, intertwining sociology and human rights. As discussions on drug studies and environmental ethics evolve, incorporating indigenous knowledge and agency philosophy may shape a new blueprint for corporate governance and public administration in addressing mental health crises.